RF Targeted Vertebral Augmentation

RF Targeted Vertebral Augmentation (RF-TVA)™ with the StabiliT® System

RF-TVA™ is the next generation in the treatment of vertebral compression fractures.


During the procedure: (1) a small articulating instrument is placed into the vertebra, (2) a cavity is created and (3) thick bone cement is delivered which flows through the cavity and fills the surrounding bone(3) stabilizing the fracture.

If you are considering RF-TVA™, there are several aspects to consider:

• Procedures are typically performed at a hospital or Ambulatory Surgery Center on an outpatient basis
• Procedures take 30-40 minutes under local anesthesia to complete
• Small puncture to the skin typically covered with a band aid
• Patients can go home the same day or the following day depending on overall health of patient

As with most surgical procedures, serious adverse events, some of which can be fatal, can occur. Although RF-TVA™ is designed to minimize these risks as much as possible, potential serious adverse events that can occur include:

• myocardial infarction (heart attack)
• pulmonary embolism (cement leakage that migrates to the lungs)
• cerebrovascular accident (stroke)
• cardiac arrest (heart stops beating)
• paralysis or muscle weakness
• death

A prescription is required. Please consult your physician for a discussion of these and other risks and if this procedure is right for you.

To learn more about RF Targeted Vertebral Augmentation (RF-TVA)™, visit www.dfineinc.com. Hear from patients who have undergone RF-TVA™ with the StabiliT Vertebral Augmentation System.